Patents by Inventor Stuart Pollard

Stuart Pollard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140154783
    Abstract: The present invention relates to molecular biology, molecular genetics, and bioprocessing. The embodiments provide for compositions and methods for producing a biological product, such as an immunogenic agent, in an embryonated egg by introducing into the egg a RNA effector molecule capable of modulating expression of a target gene, wherein the modulation enhances production of the biological product in the egg. These methods provide for RNAi-based approaches to optimize the production of biologics from embryonated eggs, such as the production of viral vaccines including seasonal and pandemic flu vaccines. The invention also relates to molecules, reagents, cells, and kits useful for carrying out the methods, and biological products produced by the methods.
    Type: Application
    Filed: July 6, 2010
    Publication date: June 5, 2014
    Applicant: Alnylam Pharmaceuticals, Inc.
    Inventors: Anthony Rossomando, John M. Maraganore, Stuart Pollard, David Kocisko, Muthiah Manogaran, Todd Borland, Shannon Hogan
  • Publication number: 20140099666
    Abstract: The invention provides compositions and methods for producing a biological product from a host cell. In various embodiments, the biological product is a polypeptide, a metabolite, a nutraceutical, a chemical intermediate, a biofuel, a food additive, or an antibiotic. In one aspect, the invention provides for a method for producing a biological product from a host cell. The method generally comprises contacting the cell with a RNA effector molecule, a portion of which is complementary to a target gene, maintaining the cell in a large-scale bioreactor for a time sufficient to modulate expression of the target gene, wherein the modulation enhances production of the biological product from the cell, and isolating the biological product from the cell.
    Type: Application
    Filed: July 6, 2010
    Publication date: April 10, 2014
    Applicant: ALNYLAM PHARMACEUTICALS, INC.
    Inventors: Anthony Rossomando, John M. Maraganore, Stuart Pollard, David Kocisko, Muthiah Manoharan, Gregory Hinkle, Brian Bettencourt, Shannon Hogan
  • Publication number: 20140004565
    Abstract: The invention provides compositions and methods for producing an immunogenic agent from a host cell. In various embodiments, the immunogenic agent is a polypeptide, an antigen, a virus particle, or a vaccine In one aspect, the invention provides for a method for producing an immunogenic agent from a host cell. The method generally comprises contacting the cell with a RNA effector molecule, a portion of which is complementary to a target gene, maintaining the cell in a large-scale bioreactor for a time sufficient to modulate expression of the target gene, wherein the modulation enhances production of the immunogenic agent from the cell, and isolating the immunogenic agent from the cell.
    Type: Application
    Filed: July 6, 2010
    Publication date: January 2, 2014
    Applicant: Alnylam Pharmaceuticals, Inc.
    Inventors: Anthony Rossomando, Muthiah Manoharan, Gregory Hinkle, Brian Bettencourt, John M. Maraganora, Stuart Pollard, David Kocisko, Shannon Hogan
  • Publication number: 20130164851
    Abstract: Provided herein are methods and compositions for generating a cell line capable of producing a biological product, using a gene amplification based system. Methods and compositions are provided to inhibit endogenous selectable amplifiable marker genes using RNA interference and prevent the selection of false positives during generation of a custom cell line. Such methods improve efficiency of cell line development and do not require the use of specialized substrates or cells lacking the endogenous selectable amplifiable marker gene to negate the effect of endogenously expressed levels of the selectable amplifiable marker gene in cells.
    Type: Application
    Filed: March 25, 2011
    Publication date: June 27, 2013
    Applicant: ALNYLAM PHARMACEUTICALS, INC.
    Inventors: Anthony Rossomando, Gregory P. Thill, Stuart Pollard
  • Publication number: 20130164329
    Abstract: The present invention relates to compositions and methods for isolating cells devoid of unwanted viral contaminants, and to methods for preparing a virus stock substantially devoid of viral contaminants. Virus stocks, cells, and immunogenic reagents produced using such methods are also provided.
    Type: Application
    Filed: February 16, 2011
    Publication date: June 27, 2013
    Applicant: Alnylam Pharmaceuticals, Inc.
    Inventors: Anthony Rossomando, John M. Maraganore, Stuart Pollard, Muthiah Manoharan
  • Patent number: 6989646
    Abstract: A system for allowing a wide selection of components to affect a desired result in the positioning business. Up to nine axes of coordinated motion are offered each of which may use a servomotor, a single or double rod air cylinder. The control for the system is a series of digital commands that cause the cylinder to accelerate, decelerate, maintain a given velocity, stop or pause and repeat a series of commands. It uses a low power servo system which, when activated, opens an air valve to an air cylinder which then moves until the valve actuator is turned off by the cylinder thus causing the air cylinder to follow the lower power servo system.
    Type: Grant
    Filed: April 24, 2003
    Date of Patent: January 24, 2006
    Inventors: Stuart Pollard Jackson, Marlin Harold Thompson, Earl Christian Close, Larry Patrick Munger, Jeffrey William Fenner, Ted Anthony Reed
  • Publication number: 20040012365
    Abstract: A system for allowing a wide selection of components to affect a desired result in the positioning business. Up to nine axes of coordinated motion are offered each of which may use a servomotor, a single or double rod air cylinder. The control for the system is a series of digital commands that cause the cylinder to accelerate, decelerate, maintain a given velocity, stop or pause and repeat a series of commands. It uses a low power servo system which, when activated, opens an air valve to an air cylinder which then moves until the valve actuator is turned off by the cylinder thus causing the air cylinder to follow the lower power servo system.
    Type: Application
    Filed: April 24, 2003
    Publication date: January 22, 2004
    Inventors: Stuart Pollard Jackson, Marlin Harold Thompson, Earl Christian Close, Larry Patrick Munger, Jeffrey William Fenner, Ted Anthony Reed